Levels of anti-TNF drugs do not predict Crohn’s disease recurrence after surgery, an Australian trial shows. Adalimumab concentrations did not differ significantly between patients in endoscopic remission post intestinal resection and those who have a recurrence, the multicentre study found. The finding, from a sub-study of the Post-Operative Crohn’s Endoscopic Recurrence (POCER) study, suggests non-TNF-mediated ...
Anti-TNF levels not related to Crohns disease recurrence post op
By Mardi Chapman
9 Feb 2018